GRCE insider transaction filings
Grace Therapeutics, Inc. — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen GRCE transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 11,608 @ $2.09 | EDGAR |
| 2026-01-12 | 4 | Kavuru Vimal — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Kottayil George — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | NEUGEBOREN EDWARD — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | DAVIS A BRIAN — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Kottayil George — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Kavuru Vimal — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | NEUGEBOREN EDWARD — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | DAVIS A BRIAN — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Kumar Amresh — VP Program Management | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Macdonald R. Loch — Chief Medical Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | DelAversano Robert J — Principal Financial Officer | Grant/award (A): 20,130 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Kohli Prashant — Chief Executive Officer, Director | Grant/award (A): 225,400 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | D'Andrea Carrie — VP Clinical Operations | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Grace Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GRCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →